Latest filings (excl ownership)
6-K
Current report (foreign)
25 Apr 24
6-K
Current report (foreign)
8 Apr 24
6-K
Current report (foreign)
4 Apr 24
6-K
Opthea to Participate in the 23rdAnnual Needham Virtual Healthcare Conference
4 Apr 24
6-K
Current report (foreign)
3 Apr 24
6-K
Current report (foreign)
19 Mar 24
6-K
Opthea to Participate in the Leerink Partners Global Biopharma Conference
6 Mar 24
6-K
Current report (foreign)
4 Mar 24
6-K
Opthea Reports Half-Year Financial Results and Business Updates
28 Feb 24
6-K
Current report (foreign)
20 Feb 24
6-K
Current report (foreign)
14 Feb 24
6-K
Current report (foreign)
1 Feb 24
6-K
Current report (foreign)
11 Jan 24
6-K
Current report (foreign)
27 Dec 23
6-K
Current report (foreign)
19 Dec 23
6-K
Current report (foreign)
30 Nov 23
6-K
Current report (foreign)
30 Nov 23
6-K
Opthea to Present at the Jefferies 2023 London Healthcare Conference
9 Nov 23
6-K
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
30 Oct 23
6-K
Hope Is on the Horizon Notice of Annual General Meeting and Explanatory Notes
27 Oct 23
6-K
Current report (foreign)
27 Oct 23
6-K
Current report (foreign)
2 Oct 23
20-F
2023 FY
Annual report (foreign)
28 Sep 23
6-K
Current report (foreign)
28 Sep 23
6-K
Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference
7 Sep 23
6-K
Current report (foreign)
31 Aug 23
6-K
OPT has successfully completed the placement and institutional entitlement offer components of its previously announced capital raising
28 Aug 23
6-K
Current report (foreign)
24 Aug 23
6-K
Current report (foreign)
1 Aug 23
6-K
Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302
26 Jul 23
6-K
Current report (foreign)
24 Jul 23
6-K
Current report (foreign)
13 Jul 23
6-K
Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor
10 Jul 23
6-K
Opthea Appoints Anshul Thakral as Non-Executive Director of the Board
8 Jun 23
6-K
Opthea to Present at the Jefferies 2023 Healthcare Conference
25 May 23
6-K
Current report (foreign)
17 May 23
6-K
Opthea To Present at the JMP Securities Life Sciences Conference
8 May 23
6-K
Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQ
28 Apr 23
6-K
Current report (foreign)
7 Mar 23
6-K
Opthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare Conference
6 Mar 23
Latest ownership filings
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 24
SC 13G/A
REGAL FUNDS MANAGEMENT PTY LTD
14 Feb 24
SC 13G/A
Regal Partners Ltd
15 Feb 23
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 23
SC 13G/A
REGAL FUNDS MANAGEMENT PTY LTD
14 Feb 22
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 22
SC 13G
BAKER BROS. ADVISORS LP
16 Feb 21
SC 13G/A
REGAL FUNDS MANAGEMENT PTY LTD
10 Feb 21
SC 13G
REGAL FUNDS MANAGEMENT PTY LTD
12 Nov 20